The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Q, well known for its guaranteed 100% human member base and zero survey fraud platform, is a leading U.S.-based consumer insights company. One of 1Q’s key differentiators is that its ...

A new study published in the Canadian Medical Association Journal (CMAJ) confirms what many suspected: obesity rates in ...

On July 8, 2025 — just eight months after the Federal Trade Commission (FTC or Commission) finalized the much-discussed Click ...

Maine Governor Janet Mills signed legislation renewing and expanding Maine’s New Markets Capital Investment ...

With a mega investment of 50 billion dollars, Astrazeneca has plans to expand its presence in medicines manufacturing and R&D ...